Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Race Oncology Ltd
RAONFCurrent price
1.22 USD
0 USD (0.00%)
Last closed
1.64 AUD
Company
www.raceoncology.com
ISIN
AU000000RAC3
Sector
Healthcare
Industry
Biotechnology
Exchange
AU
Capitalization
266 812 021 AUD
Yield for 12 month
+44.76 %
1Y
3Y
5Y
10Y
15Y
RAONF
Race Oncology Limited, a clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments. The company's lead product is bisantrene, a small molecule chemotherapeutic that has a clinical history with demonstrated therapeutic benefits in adult and paediatric patients. It is advancing reformulated bisantrene (RC220) to address the unmet need of patients across various oncology indications with a clinical focus on anthracycline combination to deliver cardioprotection and enhanced anticancer activity in solid tumors. The company is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. In addition, it is investigating the effect of bisantrene on the m6A RNA pathway, following independent research identifying bisantrene as the potent inhibitor of fat mass and obesity-associated protein. The company has collaborations with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong, and University of Newcastle. The company was formerly known as Coronado Resources Limited. Race Oncology Limited was incorporated in 2011 and is headquartered in Sydney, Australia. Address: Gateway, 1 Macquarie Place, Sydney, NSW, Australia, 2000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+3 978 376 AUD
Last Year
+3 114 735 AUD
Current Quarter
–
Last Quarter
+3 978 376 AUD
Current Year
+1 381 203 AUD
Last Year
+2 835 302 AUD
Current Quarter
-764 603 AUD
Last Quarter
+3 838 659 AUD
Key Figures RAONF
1 year
3 years
5 years
10 years
EBITDA
-14 114 347 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-38.63 %
PEG Ratio
–
Return On Equity TTM
-63.1 %
Wall Street Target Price
–
Revenue TTM
3 978 376 AUD
Book Value
0.11 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
1 100 963 AUD
Earnings per share
-0.079 AUD
Diluted Eps TTM
-0.079 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RAONF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RAONF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RAONF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
67.0656
Enterprise Value EBITDA
-21.5133
Price Book MRQ
14.4294
Financials RAONF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RAONF
For 52 weeks
0.64 AUD
2.08 AUD
50 Day MA
1.62 AUD
Shares Short Prior Month
–
200 Day MA
1.45 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart